Jaguar Health, Inc. (JAGX) stock
Close on Nov 12, 2026Market cap $2.07MP/E –Yield –
Jaguar Health statistics
65 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- -0.06
- 2.57
Share statisticsIndustry
- Float
- 4M
- 49M
- Shares Held by Insiders
- 17.1%
- 11.7%
Short sellingIndustry
- Short Interest
- 200,775
- –
- Short Interest Change
- 42.8%
- -0.80%
- Short % of Float
- 4.69%
- 9.01%
- Short % of Shares Outstanding
- 3.88%
- 6.30%
- Days to Cover
- 1.00
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $1039.50
- –
- 52-Week Low
- $0.36
- –
- 20-Day Moving Average
- $1.52
- –
- 50-Day Moving Average
- $4.29
- –
- 200-Day Moving Average
- $100.49
- –
- Average True Range (14)
- $0.78
- –
- Price Change (1 Week)
- -2.44%
- -1.15%
- Price Change (1 Month)
- -90.4%
- -4.87%
- Price Change (3 Months)
- -97.1%
- -21.0%
- Price Change (6 Months)
- -99.3%
- -20.6%
- Price Change (YTD)
- -99.9%
- -23.6%
- Price Change (1 Year)
- -100.0%
- -22.4%
- Price Change (3 Years)
- -100.0%
- -29.5%
- Price Change (5 Years)
- -100.0%
- -77.9%
- Price Change (10 Years)
- -100.0%
- -65.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 915,452
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.57
- 0.70
- Relative Strength Index (14)
- 36.2
- 43.4
- Volatility (1 Year)
- 1210.3%
- 80.1%
- Beta (5 Years)
- 2.17
- 1.07
MarginsIndustry
- Pretax Margin
- -132.7%
- -11.6%
- EBITDA Margin
- -86.3%
- -27.7%
Returns on capitalIndustry
- Return on Capital Employed (ROCE)
- -293.8%
- -37.9%
Financial positionIndustry
- Current Ratio
- 0.69
- 3.30
- Quick Ratio
- 0.15
- 2.39
- Interest Coverage
- -25.95
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 135.5%
- 6.82%
- Revenue Growth (3Y CAGR)
- -1.26%
- 2.25%
- Revenue Growth (5Y CAGR)
- 4.17%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.67
- 0.40
- Inventory Turnover
- 0.55
- 2.73
- Revenue Per Employee
- $591.81K
- $429.29K
- Employee Count
- 47
- 74
- WACC
- 14.1%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$36.92M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $2.06M
- $17.76M
- Net Cash Per Share
- $0.40
- $0.80
- Working Capital
- -$7.85M
- $79.99M
Cash flow (TTM)Industry
Taxes and interestIndustry
- Interest Expense
- $998.00K
- $2.90M
Scores and fair valueIndustry
- Altman Z-Score
- -18.45
- 0.23
- Piotroski F-Score
- 2
- 4
- Beneish M-Score
- -6.28
- -2.63
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | JAGX | S&P 500 | Difference | JAGX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -91.4% | -2.7% | −88.7 pts | ||
| 3 months | -96.5% | -1.7% | −94.7 pts | ||
| Year to date | -99.9% | +11.9% | −111.8 pts | ||
| 1 year | -100.0% | +12.0% | −111.9 pts | ||
| 3 years | -100.0% | +78.2% | −178.2 pts | -98.8% | +21.2% |
| 5 years | -100.0% | +73.2% | −173.2 pts | -98.0% | +11.6% |
| 10 years | -100.0% | +309.6% | −409.6 pts | -93.2% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M JAGX shares were sold short on Oct 30, 2026, up 42.8% from the previous report, or 4.69% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 41.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 200,775 | +42.8% | 546,192 | 1.0 |
| Oct 15, 2026 | 140,557 | +67.0% | 4,969,953 | 1.0 |
| Sep 30, 2026 | 84,156 | -74.2% | 6,733,241 | 1.0 |
| Sep 15, 2026 | 326,132 | +34.8% | 827,180 | 1.0 |
| Aug 31, 2026 | 242,001 | +106.8% | 151,797 | 1.6 |
| Aug 14, 2026 | 117,037 | +34.3% | 228,358 | 1.0 |
| Jul 31, 2026 | 87,153 | +68.6% | 119,074 | 1.0 |
| Jul 15, 2026 | 51,687 | -30.0% | 34,118 | 1.5 |
| Jun 30, 2026 | 73,828 | +34.0% | 122,903 | 1.0 |
| Jun 15, 2026 | 55,091 | -14.0% | 53,788 | 1.0 |
| May 29, 2026 | 64,056 | -5.1% | 166,303 | 1.0 |
| May 15, 2026 | 67,479 | -37.3% | 156,723 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?